# OnCo record nct05608044 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05608044/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05608044", "NCT05608044" ;
  schema:name "A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer"@en ;
  schema:alternateName "BOT/BAL phase 1b/2 expansion"@en ;
  schema:description "A phase 2 trial of Botensilimab in colorectal cancer, run by Agenus Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05608044/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05608044>, <https://doi.org/10.1158/1078-0432.CCR-26-1610> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-11-30" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/botensilimab/> ;
  onco:companies <https://onco.cc/companies/agenus/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/cold-vs-hot/> .